Skip to main content
رجوع
EHAB logo

Enhabit, Inc.

جودة البيانات: 100%
ذروة شراء
EHAB
NYSE Healthcare Medical - Care Facilities
KWD 13.67
▲ KWD 0.01 (0.07%)
القيمة السوقية: 693.39M
نطاق اليوم
KWD 13.65 KWD 13.68
نطاق 52 أسبوعًا
KWD 6.47 KWD 13.68
حجم التداول
600,300
متوسط 50 يوم / 200 يوم
KWD 11.93 / KWD 9.24
الإغلاق السابق
KWD 13.66

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس السهم وسيط القطاع
P/E -150.7 0.2
P/B 1.3 3.0
ROE % -0.9 3.6
Net Margin % -0.4 3.8
Rev Growth 5Y % -1.1 9.9
D/E 0.9 0.2

السعر المستهدف للمحللين

Hold
KWD 13.53 -1.0%
Low: KWD 12.00 High: KWD 14.00
مكرر الربحية المستقبلي
22.66
ربحية السهم المستقبلية
KWD 0.60
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
1.10B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2029 KWD 0.30
KWD 0.30 – KWD 0.30
1.34B 1
FY2028 KWD 0.62
KWD 0.50 – KWD 0.74
1.16B 2
FY2027 KWD 0.64
KWD 0.61 – KWD 0.68
1.15B 3

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-03-04 KWD 0.14 KWD 0.14 -1.3%
2025-11-05 KWD 0.12 KWD 0.17 +41.7%
2025-08-06 KWD 0.10 KWD 0.13 +30.0%
2025-05-07 KWD 0.07 KWD 0.10 +42.9%
2025-03-05 KWD 0.07 KWD 0.04 -42.9%
2024-11-06 KWD 0.04 KWD 0.03 -21.1%
2024-08-06 KWD 0.06 KWD 0.07 +16.7%
2024-05-08 KWD 0.05 KWD 0.07 +40.0%

Insider Trading Activity

Buy ratio (90d) 0.0%
20 transactions
Date Insider Type Shares Price Value
Mar 10, 2026
Jolley Julie Diane
EVP of Home Health Operations
sell 2,793 KWD 13.63 KWD 38,068.59
Mar 9, 2026
Jolley Julie Diane
EVP of Home Health Operations
sell 2,793 KWD 13.63 KWD 38,068.59
Mar 7, 2026
Black Dylan C
General Counsel and Secretary
other 2,422 KWD 13.61 KWD 32,963.42
Mar 7, 2026
Solomon Ryan
Chief Financial Officer
other 3,882 KWD 13.61 KWD 52,834.02
Mar 6, 2026
Black Dylan C
General Counsel and Secretary
grant 10,030 KWD 13.61 KWD 136,508.30
Mar 6, 2026
Black Dylan C
General Counsel and Secretary
other 3,747 KWD 13.61 KWD 50,996.67
Mar 6, 2026
Solomon Ryan
Chief Financial Officer
grant 12,859 KWD 13.61 KWD 175,010.99
Mar 6, 2026
Solomon Ryan
Chief Financial Officer
other 5,127 KWD 13.61 KWD 69,778.47
Mar 6, 2026
Jolley Julie Diane
EVP of Home Health Operations
grant 12,050 KWD 13.61 KWD 164,000.50
Jan 10, 2026
Bolton Jeffrey
Director
grant 3,761 KWD 9.97 KWD 37,497.17
Jan 10, 2026
Rush Gregory S
Director
grant 2,508 KWD 9.97 KWD 25,004.76
Oct 10, 2025
Ohlendorf Mark W
Director
grant 2,344 KWD 8.00 KWD 18,752.00
Aug 5, 2025
Marion Tanya Renee
Chief Human Resources Officer
grant 26,159 KWD 6.69 KWD 175,003.71
Jul 10, 2025
Schochet Barry P.
Director
grant 3,267 KWD 7.27 KWD 23,751.09
Jul 10, 2025
Rush Gregory S
Director
grant 3,439 KWD 7.27 KWD 25,001.53
Jul 1, 2025
Marion Tanya Renee
Chief Human Resources Officer
other 1,983 KWD 7.88 KWD 15,626.04
Jul 1, 2025
Jolley Julie Diane
EVP of Home Health Operations
other 3,032 KWD 7.88 KWD 23,892.16
Jun 26, 2025
Bolton Jeffrey
Director
grant 15,773 KWD 9.51 KWD 150,001.23
Jun 26, 2025
Brown-Stevenson Tina L.
Director
grant 15,773 KWD 9.51 KWD 150,001.23
May 1, 2025
Abou-Oaf Ehab
Pres. Int'l Fam. Care & Prof.
other 2,732

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

النقاط الرئيسية

Revenue declined -1.07% annually over 5 years
Generating 65.80M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3.51%
Capital efficient — spends only 0.46% of revenue on capex
ROIC of 4.63% — low return on invested capital
Interest coverage of 1.88× — tight debt servicing

النمو

Revenue Growth (5Y)
-1.07%
Revenue (1Y)2.44%
Earnings (1Y)N/A
FCF Growth (3Y)21.06%

الجودة

Return on Equity
-0.87%
ROIC4.63%
Net Margin-0.43%
Op. Margin6.02%

الأمان

Debt / Equity
0.94
Current Ratio1.63
Interest Coverage1.88

التقييم

P/E Ratio
-150.74
Forward P/E22.66
P/B Ratio1.30
EV/EBITDA18.02
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 2.44% Revenue Growth (3Y) 0.65%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -1.07% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1.06B Net Income (TTM) -4.60M
ROE -0.87% ROA -0.39%
Gross Margin 46.92% Operating Margin 6.02%
Net Margin -0.43% Free Cash Flow (TTM) 65.80M
ROIC 4.63% FCF Growth (3Y) 21.06%
Safety
Debt / Equity 0.94 Current Ratio 1.63
Interest Coverage 1.88
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -150.74 Forward P/E 22.66
P/B Ratio 1.30 P/S Ratio 0.65
PEG Ratio 1.05 Forward PEG N/A
EV/EBITDA 18.02 Fwd EV/EBITDA 30.11
Forward P/S 0.63 Fwd Earnings Yield 4.41%
FCF Yield 9.49%
Market Cap 693.39M Enterprise Value 1.15B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1.06B 1.03B 1.05B 1.07B 1.11B
Net Income -4.60M -156.20M -80.50M -40.40M 111.10M
EPS (Diluted) -0.09 -3.11 -1.61 1.25 28.49
Gross Profit 497.30M 504.00M 510.70M 545.50M 592.70M
Operating Income 63.80M -115.10M -47.60M -11.40M 142.90M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1.17B 1.23B 1.43B 1.53B 1.72B
Total Liabilities 603.00M 672.10M 731.90M 751.50M 236.70M
Shareholders' Equity 534.00M 523.50M 669.70M 741.70M 1.47B
Total Debt 500.00M 569.50M 610.10M 625.20M 56.90M
Cash & Equivalents 43.60M 28.40M 27.40M 22.90M 5.40M
Current Assets 205.60M 192.70M 210.10M 211.80M 178.80M
Current Liabilities 126.30M 126.20M 137.70M 132.90M 136.50M